Key result
Six-month COVID-19 recovery linked to more large, less atherogenic LDL particles versus acute infection.
Why the study?
This study aimed to investigate the atherogenicity and quality of LDL particles in patients with acute COVID-19 infection and those recovered from it.
Observational (n=63)
COVID-19 infection is associated with oxidative modification and increased atherogenicity of LDL particles, which persists as a sequel even six months after recovery.
Answers are grounded in this paper and cite their sources.
May signal heightened CV risk in COVID-19 survivors; hypothesis-generating and requires prospective validation before clinical adoption.
This study aimed to investigate the atherogenicity (quality) of LDL particles in patients with acute and recovered from COVID-19 infection. The participants were adults, aged 18 years or older of both sexes. Those with positive RT-PCR results at baseline were included in the Acute COVID-19 group (n=33), and those with negative RT-PCR six months after acute infection, were included in the Recovered COVID-19 group (n=30). The LDL quality was evaluated using three validated methods: Z-scan, UV-visible spectroscopy, and Lipoprint. The Recovered COVID-19 group showed significantly higher numbers of large LDL particles (less atherogenic) than the Acute COVID-19 group (P<0.05). We also found that COVID-19 infection was associated with the oxidative modification of LDL particles. D-dimer and CRP levels were correlated with Z-scan results and antioxidant-amount estimate. Moreover, we noticed that the infection left a sequel in LDL quality, even after six months of recovery. These findings highlight the importance of monitoring lipids during and after recovery from COVID-19 infection, and their potential deleterious effect on the LDL profile might correlate with the progression of atherosclerosis and poor clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Lotfollahi et al. (2023) conducted an observational in COVID-19 (n=63). Acute COVID-19 infection vs. Recovered COVID-19 (six months post-infection) was evaluated on Number of large LDL particles (p=<0.05). Patients recovered from COVID-19 for six months had higher numbers of large, less atherogenic LDL particles compared to those with acute infection.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: